Tanke Biosciences Corporation (TNBI) financials · rev $28.6M
Tanke Biosciences Corporation (TNBI) rev $28.6M.
| Line | FY2012 | FY2011 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | $28.56M | $23.83M | |
| Cost of Revenue | $18.62M | $15.06M | |
| Gross Profit | $9.94M | $8.77M | |
| Operating Income | $4.53M | $1.74M | |
| Net Income | −$210.25K | −$3.14M | |
| EPS (Diluted) | — | −$0.24 | |
| Unlock 4 years of statements: Lician Pro $149/yr | |||
| Line | FY2012 | FY2011 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $28.85M | $24.89M | |
| Current Assets | — | $18.91M | |
| Cash & Equivalents | $6.17M | $7.70M | |
| Inventory | — | $1.19M | |
| PP&E | — | $4.77M | |
| Total Liabilities | $12.93M | $9.03M | |
| Current Liabilities | — | $3.55M | |
| Short-term Debt | — | $785.46K | |
| Long-term Debt | — | $628.37K | |
| Total Debt | — | $1.41M† | |
| Shareholders' Equity | — | $15.85M | |
| Retained Earnings | — | $2.70M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2012 | FY2011 | Pro (1 older periods with Lician Pro) |
|---|---|---|---|
| Investing Cash Flow | −$1.53M | −$3.56M | |
| Financing Cash Flow | $1.12M | $5.82M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2012
FAQ
What is TNBI P/E and revenue?
Tanke Biosciences Corporation (TNBI) rev $28.6M.
What is TNBI revenue?
Tanke Biosciences Corporation last cached revenue is $28.6M (FY2012).
Is TNBI profitable?
Tanke Biosciences Corporation last cached net income is -$210.2K (FY2012).
What are TNBI total assets?
Tanke Biosciences Corporation last cached total assets are $28.8M (FY2012).
What is TNBI free cash flow?
No cached cash-flow row for TNBI yet.
Not investment advice. Figures as reported in company filings, not a live feed.